Aspen Neuroscience Inc.

Status: Publicly traded

Last reviewed: November 2026

Direct answer

Aspen Neuroscience Inc. is publicly traded on NASDAQ under the ticker ASPE.

Aspen Neuroscience, Inc. is a clinical-stage regenerative medicine biotechnology company, which engages in the development of autologous induced pluripotent stem cell (iPSC)-derived therapies to address neurodegenerative diseases. Its product candidate, sasineprocel, is an investigational single-dose, autologous iPSC-based cell therapy for the treatment of Parkinson's disease (PD). The company was founded by Jeanne...

Can you invest in Aspen Neuroscience Inc.?

Yes. Aspen Neuroscience Inc. trades publicly on NASDAQ as ASPE.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Aspen Neuroscience Inc.

Detailed equity research is provided by MarketSnap.